The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.

Conditions

  • Amyotrophic Lateral Sclerosis

Intervention

  • Zilucoplan
  • Verdiperstat
  • CNM-Au8
  • Pridopidine
  • SLS-005 Trehalose
  • ABBV-CLS-7262
  • DNL343

Principal Investigator

  • Rosenfeld, Jeffrey

Sponsor

  • Healy Center for ALS at Mass General

*The source of data for this particular study is "ClinicalTrials.gov" and was last updated on 05/16/2024. Loma Linda University does not make any warranties, expressed or implied, with respect to such data, and, furthermore, assumes no liability for any party's use, or the results of such use of the data.

Request Information

Complete the form below to contact the study team and receive more information about this trial.